| Literature DB >> 33139833 |
Ammar Abdulrahman Jairoun1, Moyad Shahwan2, Sa'ed H Zyoud3,4.
Abstract
A specific safety concern is the possibility that a dietary supplement could be contaminated with heavy metals. This research was undertaken to investigate the daily exposure levels of heavy metals in dietary supplements available in the UAE and to explore the factors associated with the contamination of dietary supplements with heavy metals. A total of 277 dietary supplement samples were collected from the UAE market and prepared for the analysis of selected heavy metal contamination. Inductively coupled plasma mass spectrometry (ICP-MS) was used to determine the presence of heavy metals. The average daily intake of cadmium was 0.73 μg [95% CI 0.61-0.85], compared to the acceptable daily intake (ADI) of 6 μg; the daily intake of lead was 0.85 μg [95% CI 0.62-1.07], compared to the acceptable daily intake (ADI) of 20 μg; and the daily intake of arsenic was 0.67 μg [95% CI 0.57-0.78], compared to the acceptable daily intake of 10 μg. Although the dietary supplements available in the UAE have low levels of heavy metal contamination, numerous individuals are consuming a number of different dietary supplements every day and thereby may experience a cumulative level of toxic exposure. Dietary supplements formulations (Categories), dosage forms and country of origin are strong determents of heavy metal contamination in dietary supplements products.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33139833 PMCID: PMC7606431 DOI: 10.1038/s41598-020-76000-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Number and percentages of sample baseline characteristics.
| Characteristics | Groups | Frequency | Percentage |
|---|---|---|---|
| DS combination of ingredients | Herbal/botanical supplements | 121 | 43.7 |
| Vitamins | 19 | 6.9 | |
| Minerals | 5 | 1.8 | |
| Vitamins + minerals | 23 | 8.3 | |
| Vitamins + herbs | 9 | 3.2 | |
| Minerals + herbs | 26 | 9.4 | |
| Vitamins + minerals + herbs | 30 | 10.8 | |
| Herbs + vitamins + minerals + fatty acids + enzymes | 13 | 4.7 | |
| Herbs + probiotics + enzymes + fatty acids | 20 | 7.2 | |
| Amino acids + collagen | 11 | 4 | |
| Dosage forms | Powder/liquid | 13 | 4.7 |
| Tablet | 71 | 25.6 | |
| Soft gel | 23 | 8.3 | |
| Capsule | 157 | 56.7 | |
| Caplet | 13 | 4.7 | |
| Country of origin | USA | 168 | 60.6 |
| India | 25 | 9 | |
| EU | 48 | 17.3 | |
| Canada | 28 | 10.1 | |
| Australia | 8 | 2.9 |
Results of daily intake (μg/g) of heavy metals from dietary supplement products compared to acceptable daily intake (ADI).
| Heavy metal | ADI (μg) | Daily intake | |||||
|---|---|---|---|---|---|---|---|
| Mean | ± SD | 95% CI | Median | Q3–Q1 | |||
| Cadmium (Cd) | 6.00 | 0.73 | ± 1.03 | 0.61 | 0.85 | 0.47 | 0.84–0.18 |
| Lead (Pb) | 20.00 | 0.85 | ± 1.94 | 0.62 | 1.07 | 0.52 | 0.88–0.25 |
| Arsenic (As) | 10.00 | 0.67 | ± 0.89 | 0.57 | 0.78 | 0.49 | 0.81–0.21 |
Daily intake (μg) of heavy metals from dietary supplement products according to sample baseline characteristics.
| DS categories | Groups | Cd daily intake | Pb daily intake | As Daily intake | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean | ± SD | Mean | ± SD | Mean | ± SD | |||||
| Herbal supplements | 0.65 | 0.81 | < 0.001 | 0.88 | 2.72 | 0.666 | 0.69 | 1.02 | < 0.001 | |
| Vitamins + minerals | 0.41 | 1.26 | 0.53 | 1.20 | 0.19 | 0.28 | ||||
| Vitamins + minerals + herbs | 0.83 | 1.04 | 0.81 | 0.66 | 0.74 | 0.60 | ||||
| Amino acids + collagen | 0.19 | 0.33 | 0.76 | 1.21 | 0.65 | 1.04 | ||||
| Herbs + vitamins + minerals + fatty Acids + enzymes | 1.36 | 0.97 | 1.13 | 0.61 | 0.98 | 0.55 | ||||
| Herbs + probiotics + enzymes + fatty acids | 1.51 | 1.27 | 1.40 | 1.21 | 1.40 | 1.21 | ||||
| Dosage forms | Powder/liquid | 1.14 | 1.80 | 0.030 | 1.52 | 1.92 | 0.164 | 2.17 | 2.77 | < 0.001 |
| Tablet | 0.81 | 1.16 | 1.12 | 3.55 | 0.57 | 0.52 | ||||
| Soft gel | 1.22 | 1.33 | 1.29 | 1.32 | 1.24 | 1.31 | ||||
| Capsule | 0.60 | 0.82 | 0.61 | 0.53 | 0.54 | 0.40 | ||||
| Caplet | 0.50 | 0.34 | 0.77 | 0.68 | 0.48 | 0.35 | ||||
| Country of origin | USA | 0.76 | 1.02 | 0.41 | 0.74 | 0.83 | 0.007 | 0.76 | 1.04 | 0.082 |
| India | 0.97 | 1.66 | 2.19 | 5.7 | 0.70 | 0.73 | ||||
| EU | 0.54 | 0.88 | 0.58 | 1.1 | 0.40 | 0.41 | ||||
| Canada | 0.78 | 0.56 | 0.86 | 0.66 | 0.77 | 0.55 | ||||
| Australia | 0.39 | 0.19 | 0.56 | 0.62 | 0.24 | 0.20 | ||||
Univariate and multivariate analysis of factors associated with Cd daily intake.
| Factors | Cd daily intake (μg) | |||||||
|---|---|---|---|---|---|---|---|---|
| Univariate | Multivariate | |||||||
| β | 95% CI | β | 95% CI | |||||
| Amino acids + collagen | Ref | – | – | – | – | |||
| Herbal supplements | 0.46 | − 0.15 | 1.073 | 0.14 | – | – | – | – |
| Vitamins + minerals | 0.22 | − 0.43 | 0.88 | 0.49 | – | – | – | – |
| Vitamins + minerals + herbs | 0.64 | 0.01 | 1.27 | 0.048 | – | – | – | – |
| Herbs + vitamins + minerals + fatty acids + enzymes | 1.17 | 0.37 | 1.96 | 0.004 | 0.725 | 0.168 | 1.282 | 0.011 |
| Herbs + probiotics + enzymes + fatty acids | 1.32 | − 0.39 | 0.78 | < 0.001 | 0.876 | 0.421 | 1.331 | < 0.001 |
| Caplet | Ref | – | – | – | – | |||
| Powder/liquid | 0.63 | − 0.015 | 1.42 | 0.11 | – | – | – | – |
| Tablet | 0.31 | − 0.29 | 0.91 | 0.31 | – | – | – | – |
| Soft gel | 0.71 | 0.02 | 1.40 | 0.04 | – | – | – | – |
| Capsule | 0.10 | − 0.48 | 0.68 | 0.73 | – | – | – | – |
| Australia | Ref | – | – | – | – | |||
| USA | 0.36 | − 0.37 | 1.09 | 0.34 | – | – | – | – |
| India | 0.57 | − 0.25 | 1.39 | 0.18 | – | – | – | – |
| EU | 0.14 | − 0.63 | 0.91 | 0.72 | – | – | – | – |
| Canada | 0.38 | − 0.43 | 1.19 | 0.36 | – | – | – | – |
P values less than 0.05 were considered statistically significant, “–” not included in the multivariate linear regression model.
β, beta coefficient; CI, confidence interval.
Univariate and multivariate analysis of factors associated with Pb daily intake.
| Factors | Pb Daily intake (μg) | |||||||
|---|---|---|---|---|---|---|---|---|
| Univariate | Multivariate | |||||||
| β | 95% CI | β | 95% CI | |||||
| Amino acids + collagen | Ref | – | – | – | – | |||
| Herbal supplements | 0.12 | − 1.09 | 1.33 | 0.85 | – | – | – | – |
| Vitamins + minerals | − 0.23 | − 1.51 | 1.06 | 0.73 | – | – | – | – |
| Vitamins + minerals + herbs | 0.048 | − 1.20 | 1.29 | 0.94 | – | – | – | – |
| Herbs + vitamins + minerals + fatty acids + enzymes | 0.37 | − 1.20 | 1.94 | 0.64 | – | – | – | – |
| Herbs + probiotics + enzymes + fatty acids | 0.64 | − 0.79 | 2.08 | 0.38 | – | – | – | – |
| Caplet | Ref | – | – | – | – | |||
| Powder/liquid | 0.75 | − 0.74 | 2.242 | 0.32 | – | – | – | – |
| Tablet | 0.35 | − 0.79 | 1.49 | 0.55 | – | – | – | – |
| Soft gel | 0.53 | − 0.79 | 1.85 | 0.43 | – | – | – | – |
| Capsule | − 0.16 | − 1.25 | 0.94 | 0.78 | − 0.75 | − 1.21 | − 0.29 | 0.002 |
| Australia | Ref | – | – | – | – | |||
| USA | 0.18 | − 1.18 | 1.54 | 0.79 | – | – | – | – |
| India | 1.64 | 0.12 | 3.17 | 0.035 | 1.599 | 0.83 | 2.37 | < 0.001 |
| EU | 0.03 | − 1.40 | 1.46 | 0.97 | – | – | – | – |
| Canada | 0.30 | − 1.20 | 1.80 | 0.69 | – | – | – | – |
P values less than 0.05 were considered statistically significant, “–” not included in the multivariate linear regression model.
β, beta coefficient; CI, confidence interval.
Univariate and multivariate analysis of factors associated with As daily intake.
| Factors | As daily intake (μg) | |||||||
|---|---|---|---|---|---|---|---|---|
| Univariate | Multivariate | |||||||
| β | 95% CI | β | 95% CI | |||||
| Amino acids + collagen | Ref | – | – | – | – | |||
| Herbal supplements | 0.04 | − 0.49 | 0.56 | 0.89 | ||||
| Vitamins + minerals | − 0.46 | − 1.02 | 0.10 | 0.11 | − 0.55 | − 0.79 | − 0.31 | 0.000 |
| Vitamins + minerals + herbs | 0.09 | − 0.45 | 0.63 | 0.75 | – | – | – | – |
| Herbs + vitamins + minerals + fatty acids + enzymes | 0.33 | − 0.35 | 1.01 | 0.34 | – | – | – | – |
| Herbs + probiotics + enzymes + fatty acids | 0.75 | 0.13 | 1.38 | 0.018 | 0.53 | 0.16 | 0.89 | 0.005 |
| Caplet | Ref | – | – | – | – | |||
| Powder/liquid | 1.69 | 1.07 | 2.32 | < 0.001 | 1.65 | 1.219 | 2.075 | < 0.001 |
| Tablet | 0.09 | − 0.38 | 0.57 | 0.69 | – | – | – | – |
| Soft gel | 0.76 | 0.21 | 1.31 | 0.007 | 0.52 | 0.18 | 0.86 | 0.003 |
| Capsule | 0.06 | − 0.40 | 0.51 | 0.81 | – | – | – | – |
| Australia | Ref | – | – | – | – | |||
| USA | 0.51 | − 0.12 | 1.14 | 0.11 | – | – | – | – |
| India | 0.46 | − 0.25 | 1.16 | 0.20 | – | – | – | – |
| EU | 0.15 | − 0.51 | 0.82 | 0.65 | – | – | – | – |
| Canada | 0.52 | − 0.17 | 1.22 | 0.14 | – | – | – | – |
P values less than 0.05 were considered statistically significant, “–-” not included in the multivariate linear regression model.
β, beta coefficient; CI, confidence interval.